Brief: 3SBio Announces Tpiao Injection gets Approval For Clinical Trials For Additional Indication By CFDA
22/02/2018 13:53
Feb 22 (Reuters) - 3SBio Inc 1530.HK :
* TPIAO INJECTION GRANTED APPROVAL FOR CLINICAL TRIALS FOR
ADDITIONAL INDICATION BY CHINA FOOD AND DRUG ADMINISTRATION
Source text for Eikon: ID:nHKS6sk8dB
Further company coverage: 1530.HK
((Bangalore.newsroom@thomsonreuters.com;))